The southend pre-test probability score (SPTPS) was recently developed to estimate the probability of giant cell arteritis (GCA) based on symptoms, signs and lab findings. In this interview with Prof. Bhaskar Dasgupta (Southend University Hospital NHS Foundation Trust, Southend-on-Sea, UK) we discuss the validation study of SPTPS and how effective the score was in assessing the clinical probability of GCA among suspected new cases.
This information is brought to you by Touch Medical Media and is not sponsored by, nor a part of, the American College of Rheumatology.
The abstract ‘Probability-based Diagnostic Algorithm in Suspected Giant Cell Arteritis: A Prospective, Multicentre Validity Data from HAS GCA Study‘ (Abstract number: 1620) was presented at the ACR Convergence, November 10–14, 2022.
Questions
- Can you give us a brief overview of the Southend pre-test probability score (SPTPS)? (0:05)
- What was the methodology of your validation study of SPTPS? (1:55)
- How effective was the SPTPS in assessing the clinical probability of GCA among people with suspected new onset GCA? (5:44)
Disclosures:Â Bhaskar Dasgupta discloses consulting for Sanofi; receiving grant/ research support from Sanofi; and receiving honoraria from Sanofi.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Gina Furnival.
Filmed in coverage of the ACR Convergence 2022.
